Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-18
2008-12-09
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S094000
Reexamination Certificate
active
07462628
ABSTRACT:
Preventives/remedies for voiding disturbance containing a compound having both of an acetylcholinesterase inhibitory action and an α1 antagonistic action which exhibits an excellent effect of improving the urinary function of the bladder (i.e., effects of improving urine flow rate and voiding efficiency) without affecting the urinary pressure or the blood pressure.
REFERENCES:
patent: 3917838 (1975-11-01), Bass et al.
patent: 0 487 071 (1992-05-01), None
patent: 0 560 235 (1993-09-01), None
patent: 0 562 832 (1993-09-01), None
patent: 0 567 090 (1993-10-01), None
patent: 0 607 864 (1994-07-01), None
patent: 0 655 451 (1995-05-01), None
patent: 1 088 551 (2001-04-01), None
patent: 1 118 322 (2001-07-01), None
patent: 1 489 088 (1977-10-01), None
patent: 6-263733 (1994-09-01), None
patent: 7-330725 (1995-12-01), None
patent: 7-330726 (1995-12-01), None
patent: 8-92080 (1996-04-01), None
patent: 9-143182 (1997-06-01), None
patent: 10-45597 (1998-02-01), None
patent: 99/19326 (1999-04-01), None
patent: 99/42448 (1999-08-01), None
patent: 00/51985 (2000-09-01), None
patent: 01/16105 (2001-03-01), None
European Office Action mailed Dec. 19, 2007 for European Application No. 02790890.4-1216.
Beilstein Registry No. 7871165, Bellstein Data: Copyright 1988-2007, Beilstein Institute.
Beilstein Registry No. 7498409, Beilstein Data: Copyright 1988-2007, Beilstein Institute.
K. Yasuda et al. “The effect of unrapidil on neurogenic bladder: a placebo controlled double-blind study”,The Journal of Neurology, Sep. 1996, vol. 156, pp. 1125-1130.
M. Perrigot et al., “Effect of intravenous alfuzosin on urethral pressure in patients with neurogenic bladder dysfunction”,Neurology and Urodynamics, 1996, vol. 15, pp. 119-131.
Doi Takayuki
Ikeuchi Motoki
Ishichi Yuji
Ishihara Yuji
Kanzaki Naoyuki
Rahmani Niloofar
Seaman D. Margaret
Takeda Pharmaceutical Company Limited
Wenderoth, Linds & Ponack, L.L.P.
LandOfFree
Preventives/remedies for urinary disturbance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preventives/remedies for urinary disturbance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventives/remedies for urinary disturbance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4022612